Amodiaquine clinical trials
Counted the way a researcher would: Amodiaquine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Amodiaquine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Amodiaquine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
63 studies that test it; most in 2005 (6)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 55
London School of Hygiene and Tropical Medicine (16) · Malaria Consortium (5) · University of Oxford (4) · Centre Muraz (4) · Sanofi (4) · Ministry of Public Health, Democratic Republic of the Congo (3) · Centers for Disease Control and Prevention (3) · University of California, San Francisco (2)
Often tested with
Tested in the same studies.
Artesunate (32) · Fanasil, pyrimethamine drug combination (21) · Artemether, Lumefantrine Drug Combination (17) · Artenimol (9) · Piperaquine (9) · Chloroquine (5) · Primaquine (4) · Sulfadoxine (4)
Studies
Open first, then newest update. How each study uses Amodiaquine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 63
- Perennial Malaria Chemoprevention in the Malaria Vaccine EraNot yet recruitingPhase 4Stanford UniversityNCT07322068Written as Sulfadoxine pyrimethamine + AmodiaquineHow we know
- Seasonal Malaria Chemoprevention Rapid Assessment Study MozambiqueNot yet recruitingPhase 4Malaria ConsortiumNCT06337253Written as Sulfadoxine/pyrimethamine plus amodiaquineHow we know
- Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth ControlNot yet recruitingNot applicableLondon School of Hygiene and Tropical MedicineNCT06182176Written as Sulphadoxine-pyrimethamine and AmodiaquineHow we know
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingPhase 3Malaria ConsortiumNCT05946642Written as Sulphadoxine-Pyrimethamine/AmodiaquineHow we know
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, MalawiCompletedPhase 4Liverpool School of Tropical MedicineNCT06083688Written as Sulfadoxine-pyrimethamine-amodiaquineHow we know
- Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy SubjectsTerminatedPhase 1University of OxfordNCT04080895Written as AmodiaquineHow we know
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.CompletedPhase 3University of OxfordNCT03923725Written as Artemether-lumefantrine+ Amodiaquine (AL+AQ)How we know
- Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19CompletedPhase 2Shin Poong Pharmaceutical Co. Ltd.NCT04532931Written as Artesunate-amodiaquineHow we know
- Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant WomenCompletedPhase 3London School of Hygiene and Tropical MedicineNCT00131703Written as AmodiaquineHow we know
- Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the CongoCompletedPhase 4Ministry of Public Health, Democratic Republic of the CongoNCT06076213Written as Artesunate-amodiaquineHow we know
- Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in MaliCompletedPhase 2London School of Hygiene and Tropical MedicineNCT05550909Written as AmodiaquineHow we know
- Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in LiberiaCompletedPhase 4Centers for Disease Control and PreventionNCT06300970Written as Amodiaquine-artesunate (ASAQ)How we know
- Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South SudanActive, not recruitingPhase 3Malaria ConsortiumNCT05471544Written as AmodiaquineHow we know
- Intermittent Preventive Treatment of Malaria in SchoolchildrenCompletedPhase 3London School of Hygiene and Tropical MedicineNCT00852371Written as amodiaquine + sulfadoxine-pyrimethamineHow we know
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)CompletedPhase 3University of OxfordNCT03939104Written as Artemether-lumefantrine+amodiaquineHow we know
- Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, UgandaActive, not recruitingPhase 4Malaria ConsortiumNCT05323721Written as Sulfadoxine pyrimethamine and amodiaquineHow we know
- Chemoprevention Efficacy Study in Burkina FasoActive, not recruitingPhase 4Malaria ConsortiumNCT05478954Written as AmodiaquineHow we know
- Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+AmodiaquinStatus unknownPhase 3University Clinical Research Center, MaliNCT04149106Written as Sulfadoxine pyrimethamine + AmodiaquinHow we know
- Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the CongoCompletedPhase 4Ministry of Public Health, Democratic Republic of the CongoNCT04618523Written as Artesunate-amodiaquineHow we know
- Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in MaliCompletedPhase 2London School of Hygiene and Tropical MedicineNCT05081089Written as Sulphadoxine-pyrimethamine with amodiaquineHow we know
See all 63 studies that test Amodiaquine →
Given beside what is tested · 3 — Amodiaquine is usual care or a partner of the new treatment
- Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African ChildrenStatus unknownNot applicableLondon School of Hygiene and Tropical MedicineNCT05354258Written as AmodiaquineHow we know
- Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With MalariaCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT01955382Written as AmodiaquineHow we know
- Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in MaliCompletedNot applicableAlliance for International Medical ActionNCT03035305Written as Seasonal malaria chemopreventionHow we know
As the comparator · 5 — what is tested is compared with Amodiaquine
- Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in TanzaniaCompletedPhase 3National Institute for Medical Research, TanzaniaNCT03640403Written as Artesunate-amodiaquineHow we know
- Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With MalariaCompletedPhase 3Institute of Tropical Medicine, BelgiumNCT00852423Written as Artesunate-amodiaquineHow we know
- Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in GhanaCompletedPhase 3Kwame Nkrumah University of Science and TechnologyNCT01231113Written as artesunate-amodiaquineHow we know
- A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated MalariaCompletedPhase 1/2SanofiNCT00563914Written as amodiaquineHow we know
- Randomized Trial on Effectiveness of ACTs in GhanaTerminatedPhase 4Bernhard Nocht Institute for Tropical MedicineNCT00374205Written as Artesunate plus AmodiaquineHow we know
Codes
What other systems call Amodiaquine · ClinicalTrials.gg INT006960
- MeSH (NLM) D000655AmodiaquineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 220236ED28AMODIAQUINEConfirmed FDA, NLM, Wikidata
- RxNorm 720Confirmed FDA, Wikidata
- Wikidata Q239569amodiaquineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65231AmodiaquineOne source FDA
- DrugBank DB00613One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000655 | Amodiaquine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 220236ED28 | AMODIAQUINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 720 | — | Confirmed FDA, Wikidata |
| Wikidata | Q239569 | amodiaquine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65231 | Amodiaquine | One source FDA |
| DrugBank | DB00613 | — | One source Wikidata |
Also registered as amodiaquine hydrochloride (UNII K6PW2S574L · RxNorm 314495).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.